Latest filing published 10 Oct 2018 for Emmaus Life Sciences, Inc., €173k.
Insider track record
No signal scores available.
Michal Votruba: trading record in brief
Michal Votruba discloses dealings in Emmaus Life Sciences, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 5 April 2016 to 8 October 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 20 November 2018: a share grant of €173k, in Emmaus Life Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 23 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michal Votruba
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 144,000 shares@ US$1.38COMMON STOCKSEC:0001615774-18-010703:0
- 250,000 shares0Common StockSEC:0001615774-16-004868:0
2 of 2 declarations